Synthesis, characterization and crystal structures of two alkaline-earth metal complexes of olsalazine

Calcium Coordination Solids for pH-Triggered Release of Olsalazine

Calcium coordination solids were synthesized and evaluated for delivery of olsalazine (H₄ olz), an anti-inflammatory compound used for treatment of ulcerative colitis. The materials include one-dimensional Ca(H₂ olz)⋅4 H₂ O chains, two-dimensional Ca(H₂ olz)⋅2 H₂ O sheets, and a three-dimensional metal-organic framework Ca(H₂ olz)⋅2DMF (DMF=N,N-dimethylformamide). The framework undergoes structural changes in response to solvent, forming a dense Ca(H₂ olz) phase when exposed to aqueous HCl. The compounds Ca(H₂ olz)⋅x H₂ O (x=0, 2, 4) were each pressed into pellets and exposed to simulated gastrointestinal fluids to mimic the passage of a pill from the acidic stomach to the pH-neutral intestines. All three calcium materials exhibited a delayed release of olsalazine relative to Na₂ (H₂ olz), the commercial formulation, illustrating how formulation of a drug within an extended coordination solid can serve to tune its solubility and performance.

Carboxylate-phenolate tautomerism in 5-[(nitrophenyl)diazenyl]salicylate anions

Aryldiazenyl derivatives of salicylic acid and their salts are used as dyes. In these structures, the carboxylate groups are engaged in short contacts with the cations and in hydrogen bonds with water molecules, if present. If both O atoms of the carboxylate group take part in such interactions, the negative charge is delocalized over the two atoms. In the absence of hydrogen bonds and contacts with cations, the negative charge is localized on one of the O atoms. In the crystal structures of tetramethylammonium 2-hydroxy-5-[(E)-(4-nitrophenyl)diazenyl]benzoate and tetramethylammonium 2-hydroxy-5-[(E)-(2-nitrophenyl)diazenyl]benzoate, both C4H12N(+)·C13H8N3O5(-), all the interactions between the cations and anions are weak, and their effect on the geometry of the anions is negligible. Under these conditions, the 2-nitro-substituted anion is an almost pure phenol-carboxylate tautomer, whereas in the 4-nitro-substituted anion, the phenolic H atom is shifted towards the carboxylate group, and thus the structure of this anion is intermediate between the phenol-carboxylate and phenolate-carboxylic acid tautomeric forms. The probable formation of such an intermediate form is supported by quantum chemical calculations. Being the characteristic feature of this form, a short distance between the phenolic and carboxylate O atoms is observed in the 4-nitro-substituted anion, as well as in the structures of some 3,5-dinitrosalicylates reported in the literature.

A rare example of a porous Ca-MOF for the controlled release of biologically active NO

A 1D-microporous 3D calcium tetracarboxylate MOF has been solvothermally prepared and its structure solved from single crystal data. It exhibits coordinatively unsaturated Ca(2+) Lewis acid sites able to trap and deliver nitric oxide at a biological level.